EP 3319971 A1 20180516 - 1-ALKYL,2-ACYLGLYCEROPHOSPHOCHOLINES FOR THE TREATMENT OF INFLAMMATION OR OF INTESTINAL CANCER
Title (en)
1-ALKYL,2-ACYLGLYCEROPHOSPHOCHOLINES FOR THE TREATMENT OF INFLAMMATION OR OF INTESTINAL CANCER
Title (de)
1-ALKYL,2-ACYLGLYCEROPHOSPHOCHOLINE FÜR DIE BEHANDLUNG VON ENTZÜNDUNGEN ODER VON DARMKREBS
Title (fr)
1-ACETYL,2-ACYLGLYCEROPHOSPHOCHOLINES, POUR LE TRAITEMENT D'UNE INFLAMMATION OU D'UN CANCER INTESTINAL
Publication
Application
Priority
- FR 1556400 A 20150706
- FR 2016051702 W 20160705
Abstract (en)
[origin: WO2017006047A1] The invention relates to a compound of formula (I): where X and R are defined in claim i, or a drug or pharmaceutical composition comprising such a compound of formula (I) or any pharmaceutically acceptable hydrates, salts or solvates thereof, in the form of a pure isomer or a mixture of isomers in any proportion, for the use thereof in treating intestinal cancer or intestinal inflammation.
IPC 8 full level
C07F 9/10 (2006.01); A61K 31/661 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/661 (2013.01); A61P 29/00 (2017.12); A61P 35/00 (2017.12); C07F 9/10 (2013.01)
Citation (search report)
See references of WO 2017006047A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017006047 A1 20170112; EP 3319971 A1 20180516; FR 3038606 A1 20170113; FR 3038606 B1 20181005
DOCDB simple family (application)
FR 2016051702 W 20160705; EP 16747824 A 20160705; FR 1556400 A 20150706